DENVER & HOUSTON--(BUSINESS WIRE)--BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces completion of Houston Methodist’s inpatient expansion of the BioButton® continuous patient monitoring solution across all 2,653 non-ICU beds at the system’s eight hospitals.

丹佛和休斯顿--（商业新闻短讯）--持续健康监测和临床情报公司BioIntelliSense宣布，休斯顿卫理公会在该系统的八家医院的所有2653张非ICU病床上完成了BioButton®连续患者监测解决方案的住院扩展。

The FDA-cleared BioIntelliSense BioButton multiparameter wearable is applied to patients at the time of admission with centralized command center monitoring by Houston Methodist’s multi-disciplinary team. Applying AI-driven analytics to detect clinically meaningful changes in vital sign trends allows the monitoring team to proactively coordinate care with bedside staff in medical surgical units and within specialty care areas including oncology, cardiology, neurology, transplantation and maternal health..

FDA批准的BioIntelliSense BioButton多参数可穿戴设备在入院时应用于患者，由休斯顿卫理公会的多学科团队进行集中指挥中心监测。应用人工智能驱动的分析来检测生命体征趋势的临床意义变化，使监测团队能够主动协调医疗外科单位和专科护理领域（包括肿瘤学，心脏病学，神经病学，移植和孕产妇健康）的床边工作人员的护理。。

“Houston Methodist is a recognized leader in innovation and is rapidly transforming care delivery by automating vital sign collection and empowering clinicians to focus on what matters most – their patients,” said James Mault, M.D., Founder and CEO of BioIntelliSense. “This system-wide expansion of the BioButton continuous patient monitoring solution demonstrates the clinical value and economic impact of scalable exception management to help identify patients whose condition may be deteriorating as well as those with highly stable vital signs who may be candidates for earlier hospital discharge, thereby reducing length of stay.

BioIntelliSense创始人兼首席执行官詹姆斯·莫特（JamesMault）医学博士说：“休斯顿卫理公会（Houston Methodist）是公认的创新领导者，正在通过自动化生命体征收集和授权临床医生专注于最重要的事——他们的患者，迅速改变护理服务。”。“BioButton连续患者监测解决方案在全系统范围内的扩展证明了可扩展异常管理的临床价值和经济影响，以帮助识别病情可能恶化的患者以及生命体征高度稳定的患者，这些患者可能会提前出院，从而缩短住院时间。

Together with Houston Methodist, we have scaled a new standard of continuous care with a shared commitment for improving patient outcomes and safety.”.

与休斯顿卫理公会（Houston Methodist）一起，我们已经扩大了持续护理的新标准，并共同致力于改善患者的预后和安全。”。

The inpatient monitoring program – powered by the BioButton multiparameter wearable, BioCloud™ data analytics and the BioDashboard™ clinical intelligence solution – reached full scale utilization in an accelerated six-month implementation cycle. The “Vitals Redesign” initiative improves patient safety via continuous monitoring while reducing the burden of repetitive manual tasks associated with spot check vital sign measurements and documentation, enabling caregivers to spend more time focusing on efforts to mobilize patients and other activities that can further improve outcomes.

住院监测计划由BioButton多参数可穿戴、BioCloud™数据分析和BioDashboard™临床智能解决方案提供支持，在加速的六个月实施周期内实现了全面利用。“生命体征重新设计”计划通过持续监测提高了患者的安全性，同时减轻了与抽查生命体征测量和记录相关的重复性手动任务的负担，使护理人员能够花费更多时间集中精力动员患者和其他可以进一步改善结果的活动。

Furthermore, continuous monitoring via the BioButton system is also allowing patients to enjoy better sleep without being woken throughout the night for vital sign measurements..

此外，通过BioButton系统进行的连续监测还可以让患者享受更好的睡眠，而不必整夜醒来进行生命体征测量。。

Today, with the coin-sized wireless BioButton device, up to 1,440 sets of minute-level vital sign measurements are passively captured each day and for every general care patient throughout their inpatient stay. Houston Methodist’s state-of-the-art virtual command center operation monitors high frequency BioButton vital sign data and personalized trend notifications as leading indicators of potential patient deterioration.

今天，使用硬币大小的无线生物按钮设备，每天以及每个普通护理患者在住院期间都可以被动捕获多达1440组分钟级生命体征测量值。休斯顿卫理公会（Houston Methodist）最先进的虚拟指挥中心运营监控高频生物按钮生命体征数据和个性化趋势通知，作为潜在患者恶化的主要指标。

This exception-based approach to continuous patient monitoring results in low notification rates (<1 per patient per day) and high clinician engagement (99.71%) in performing clinical assessments for more efficient and proactive care..

这种基于例外情况的持续患者监测方法导致低通知率（每位患者每天少于1次）和临床医生高度参与（99.71%），以进行更有效和主动的临床评估。。

“Houston Methodist has rapidly advanced from a traditional episodic model of care to a new standard that is more continuous, personalized and proactive,” said Sarah Pletcher, M.D., System Vice President and Executive Medical Director of Strategic Innovation at Houston Methodist. “We‘ve come a long way from the days of nurses manually collecting four to six sets of patient vital signs a day to the automated capture of thousands of multiparameter measurements each day.

休斯顿卫理公会系统副总裁兼战略创新执行医学主任莎拉·普莱彻（SarahPletcher）医学博士表示：“休斯顿卫理公会已经从传统的间歇式护理模式迅速发展到了一个更加连续、个性化和主动的新标准。”。“从护士每天手动采集四到六组患者生命体征的日子到每天自动采集数千个多参数测量值的日子，我们已经走过了漫长的道路。

We are not only improving the patient experience with fewer interruptions of sleep to help facilitate their healing, but we’re also giving time back to our workforce, optimizing care workflows and empowering our care team with actionable clinical insights that increase response time and improve overall patient care.”.

我们不仅改善了患者的睡眠体验，减少了睡眠中断，有助于促进他们的康复，而且我们还将时间回馈给我们的员工，优化护理工作流程，并为我们的护理团队提供可行的临床见解，以增加响应时间并改善整体患者护理。”。

Houston Methodist is also expanding use of the BioButton solution to help triage patients with medical-grade monitoring in the emergency department while working in parallel to operationalize a hospital to home program.

休斯顿卫理公会（Houston Methodist）也在扩大生物按钮（BioButton）解决方案的使用范围，以帮助在急诊科对患者进行医疗级别监测，同时并行实施医院到家计划。

ABOUT BIOINTELLISENSE

关于生物智能

BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for virtual care and remote patient monitoring (RPM) from in-hospital to home. Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multiparameter vital signs and physiological biometrics through an effortless user experience.

BioIntelliSense开创了一个持续健康监测和临床智能的新时代，用于从医院到家庭的虚拟护理和远程患者监测（RPM）。其医疗级数据即服务（DaaS）平台通过轻松的用户体验无缝捕获多参数生命体征和生理生物特征。

The FDA-cleared BioButton® multiparameter wearable, BioHub™ gateways, BioMobile™ downloadable applications, BioCloud™ data services and the BioDashboard™ clinical intelligence system creates a comprehensive tech-enhanced solution that makes continuous monitoring reliable and scalable. Through the platform’s AI-driven analytics, clinicians have access to high-resolution patient trending and data-driven insights to deliver better, safer care from in-hospital to home..

FDA批准的BioButton®多参数可穿戴、BioHub™网关、BioMobile™可下载应用程序、BioCloud™数据服务和BioDashboard™临床智能系统创建了一个全面的技术增强解决方案，使连续监测可靠且可扩展。通过该平台的人工智能驱动分析，临床医生可以获得高分辨率的患者趋势和数据驱动的见解，从而从住院到家庭提供更好，更安全的护理。。

ABOUT HOUSTON METHODIST

关于休斯顿卫理公会

Houston Methodist is one of the nation’s leading health systems and academic medical centers. The health system consists of eight hospitals: Houston Methodist Hospital, its flagship academic hospital in the Texas Medical Center, six community hospitals and one long-term acute care hospital throughout the Greater Houston metropolitan area.

休斯顿卫理公会是美国领先的卫生系统和学术医疗中心之一。卫生系统由八家医院组成：休斯顿卫理公会医院、其在德克萨斯州医疗中心的旗舰学术医院、六家社区医院以及整个大休斯顿都市区的一家长期急症护理医院。

Houston Methodist also includes a research institute; a comprehensive residency program; international patient services; freestanding comprehensive care, emergency care and imaging centers; and outpatient facilities. Houston Methodist employs more than 32,000 people and had more than 2.1 million outpatient visits and more than 141,000 admissions in 2022.

休斯顿卫理公会还包括一个研究所；全面的住院医师计划；国际患者服务；独立的综合护理，急诊护理和成像中心；和门诊设施。休斯顿卫理公会拥有32000多名员工，2022年门诊就诊人数超过210万，入院人数超过141000人。

For more information on Houston Methodist, see houstonmethodist.org..

有关休斯顿卫理公会的更多信息，请参阅houstonmethodist.org。。